Aspira Pathlab & Diagnostics Faces Mixed Technical Signals Amid Strong Financial Performance
Aspira Pathlab & Diagnostics has experienced a recent evaluation adjustment, reflecting shifts in its technical indicators. Despite a mixed outlook from various metrics, the company has shown consistent financial performance with growth in net sales and profit, alongside a low debt-to-equity ratio and favorable valuation metrics.
Aspira Pathlab & Diagnostics has recently undergone an adjustment in evaluation, reflecting changes in its technical indicators. The stock's technical trend has shifted from a mildly bullish stance to a mildly bearish outlook. This revision is influenced by various technical metrics, including the MACD, which indicates a bullish signal on a weekly basis but a mildly bearish signal on a monthly basis. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly periods, while Bollinger Bands maintain a mildly bullish position across both timeframes. Moving averages indicate a bearish trend on a daily basis, contrasting with the bullish signals from the KST on both weekly and monthly charts. Dow Theory presents a mildly bearish view weekly, yet remains mildly bullish monthly.
Aspira Pathlab's financial performance has shown positive results over the last five consecutive quarters, with a notable growth in net sales and profit after tax. The company maintains a low debt-to-equity ratio and has demonstrated attractive valuation metrics, including a price-to-book value of 5.2.
For more insights on Aspira Pathlab & Diagnostics and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
